On November 15, Gelonghui reported that Shenzhou Cell (688520.SH) investor relations activity record shows that the company has no layout in stem cell new product development and regenerative medicine.
神州细胞(688520.SH)：公司在干细胞新产品开发、再生医学方面没有布局
Shenzhou Cell (688520.SH): The company has no layout in the development of new stem cell products and regenerative medicine.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated